Results     30-May-24
Announcements
Marksans Pharma consolidated net profit declines 4.44% in the March 2024 quarter
Sales rise 15.23% to Rs 560.01 crore
Net profit of Marksans Pharma declined 4.44% to Rs 78.29 crore in the quarter ended March 2024 as against Rs 81.93 crore during the previous quarter ended March 2023. Sales rose 15.23% to Rs 560.01 crore in the quarter ended March 2024 as against Rs 485.98 crore during the previous quarter ended March 2023.

For the full year,net profit rose 17.80% to Rs 313.70 crore in the year ended March 2024 as against Rs 266.31 crore during the previous year ended March 2023. Sales rose 17.56% to Rs 2177.41 crore in the year ended March 2024 as against Rs 1852.14 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales560.01485.98 15 2177.411852.14 18
OPM %19.5822.54 -21.0618.32 -
PBDT121.33118.12 3 497.80389.51 28
PBT100.28104.17 -4 423.53337.65 25
NP78.2981.93 -4 313.70266.31 18

Previous News
  Marksans Pharma declines after US FDA issues Form 483 with 5 observations to Goan plant
 ( Hot Pursuit - 18-Apr-24   11:52 )
  Equity barometers hit fresh intraday low; PSU bank shares witness profit booking
 ( Market Commentary - Mid-Session 19-Apr-23   14:36 )
  ISGEC Heavy Engineering Ltd leads losers in 'A' group
 ( Hot Pursuit - 30-May-24   15:00 )
  Marksans Pharma declines after Q4 PAT slides 6% YoY to Rs 78 cr
 ( Hot Pursuit - 30-May-24   14:37 )
  Nifty below 17,400 level; bank stocks under pressure
 ( Market Commentary - Mid-Session 10-Mar-23   14:37 )
  Lincoln Pharmaceuticals Ltd Surges 5.79%
 ( Hot Pursuit - 11-May-21   09:30 )
  Marksans Pharma gets USFDA nod for Famotidine tablets
 ( Hot Pursuit - 10-Mar-23   12:28 )
  Marksans Pharma gains on receiving USFDA approval for Guaifenesin tablets
 ( Hot Pursuit - 22-Aug-23   14:54 )
  Marksans Pharma standalone net profit declines 53.52% in the September 2017 quarter
 ( Results - Announcements 13-Nov-17   15:59 )
  Board of Directors of Marksans Pharma appoints director
 ( Corporate News - 11-Jul-19   12:50 )
  Marksans Pharma receives 'Certificate of GMP Compliance of a Manufacturer' for Goa facility
 ( Corporate News - 26-Apr-17   16:27 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top